AI
MIRM icon

Atria Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Atria Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,959
Closed -$273K – 2221
2026
Q1 		$273K Sell
2,959
-191
-6% -$18K ﹤0.01% 1811
2025
Q4 		$249K Buy
3,150
+149
+5% +$10.7K ﹤0.01% 1855
2025
Q3 		$220K Buy
+3,001
New +$191K ﹤0.01% 1895

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Atria Investments's MIRM Position: Q2 2026 in Review

Atria Investments sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 2,959 shares — an estimated $273K sold.

Atria Investments first reported a position in MIRM in Q3 2025 and held it in 3 quarters. The position peaked at $273K in Q1 2026. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Atria Investments reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Atria Investments sold 2,959 Mirum Pharmaceuticals shares in Q2 2026, an estimated $273K.
  • Atria Investments first reported a position in Mirum Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Atria Investments's Mirum Pharmaceuticals position peaked at $273K in Q1 2026.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.